StockDriftsStockDriftsTop 41 MPM BioImpact LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| DBVT | DBV Technologies S A | 8.41% | 5.21M | $108.9M | +423.00%(+4.22M) | $17.67(-10.46%) | 2026-03-31 | |
| CGEM | Cullinan Therapeutics, Inc. | 8.39% | 7.65M | $108.7M | +0.00%(+0) | $41.67(-57.69%) | 2026-03-31 | |
| AKTS | Aktis Oncology, Inc. | 6.68% | 4.84M | $86.5M | new | $17.89(+77.53%) | 2026-03-31 | |
| LQDA | Liquidia Corporation | 4.1% | 1.41M | $53.0M | +0.31%(+4.29K) | $27.07(+191.58%) | 2026-03-31 | |
| ALMS | Alumis Inc | 4.06% | 2.39M | $52.6M | -0.64%(-15.46K) | $6.88(+285.45%) | 2026-03-31 | |
| EWTX | Edgewise Therapeutics Inc | 4.04% | 1.66M | $52.3M | +0.33%(+5.44K) | $16.91(+134.00%) | 2026-03-31 | |
| RVMD | Revolution Medicines, Inc. | 3.81% | 506.8K | $49.3M | +0.22%(+1.10K) | $41.63(+354.59%) | 2026-03-31 | |
| AGIO | Agios Pharmaceuticals Inc | 3.41% | 1.31M | $44.2M | +0.22%(+2.89K) | $33.67(+11.60%) | 2026-03-31 | |
| CORT | Corcept Therapeutics, Inc. | 3.07% | 985.7K | $39.7M | new | $37.56(+140.21%) | 2026-03-31 | |
| TRVI | Trevi Therapeutics Inc | 3.04% | 3.30M | $39.4M | +0.35%(+11.34K) | $3.35(+434.94%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +16.03% | +56.22% |
| Top 20 Holdings Unweighted | +19.20% | +69.37% |
Sign up free to track MPM BioImpact LLC, compare funds side by side, and get alerts the moment positions change.